MusclePharm Corp - FORM 10-K - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - April 2, 2018

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - MusclePharm Corpmslp_ex312.htm
EX-32.2 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - MusclePharm Corpmslp_ex322.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - MusclePharm Corpmslp_ex311.htm
EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - MusclePharm Corpmslp_ex231.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - MusclePharm Corpmslp_ex211.htm
EX-10.17 - MATERIAL CONTRACTS - MusclePharm Corpmslp_ex1017.htm
EX-10.16 - MATERIAL CONTRACTS - MusclePharm Corpmslp_ex1016.htm
10-K - ANNUAL REPORT - MusclePharm Corpmslp_10k.htm
 
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with this Annual Report of MusclePharm Corporation (the “Company”), on Form 10-K for the year ended December 31, 2017, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Ryan Drexler, Principal Executive Officer of the Company, certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
(2)
The information contained in the Report, fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
 
 
 
 
 
Date: April 2, 2018
 
By:
/s/ Ryan Drexler
 
 
 
Ryan Drexler
 
 
 
Chief Executive Officer and President
 
 
 
(Principal Executive Officer)
 
 

MusclePharm Corp Reports